legislation: 115-hconres-146
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115-hconres-146 | 115 | hconres | 146 | Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements. | Health | 2018-12-20 | 2018-12-20 | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House | Rep. Burgess, Michael C. [R-TX-26] | TX | R | B001248 | 0 | Expresses the sense of Congress that: the efficient administration of Medicare and Medicaid encompasses federal efforts to achieve good value for funds spent in those programs; the Centers for Medicare & Medicaid Services (CMS) has the authority to require direct-to-consumer television advertisements of prescription drugs and biological products to include the drug or product's list price; and the proposed rule by the CMS published in the Federal Register on October 18, 2018, when finalized, shall be codified without change. | 2023-01-11T13:40:53Z |